Industry. 1. There will be free movement of industrial goods free of any restrictions including customs and import taxes between the two sides, subject to each side's legislation.
Industry. In the event of equipment failures, ALPS shall, at no additional expense to the Trust, take commercially reasonable steps to minimize service interruptions.
Industry. The aim of cooperation in this area is to facilitate the restructuring and modernisation of the South African industry while fostering its competitiveness and growth and to create conditions favourable to mutually beneficial cooperation between South African and Community industry. The aim of the cooperation shall be, inter alia:
Industry. 1. For the purpose of promoting industrial development of Member States and integrating their economies, Member States shall within the Community harmonize their industrialisation policies.
Industry. 1. A strong, competitive forest sector based on sustainably managed publicly and privately owned native forests and plantations, profitable production and infrastructure and capable of innovation and investment.
Industry. The term “
Industry. (A) In general The term ‘‘industry’’ means the producers as a whole of a domestic like product, or those producers whose collective output of a domestic like product constitutes a major proportion of the total domestic production of the product.
Industry. Pursuant to Article 201 of the Basic Agreement:
Industry. CompBioMed will target the HPC and biomedical (including pharmaceutical) industries, including software and hardware resource users, resource providers, developers, researchers, CEOs and other leaders. The XxX will act as an innovation incubator. Academia will work with industry to exploit the XxX’x capabilities by raising awareness of and providing support within industrial contexts especially, but by no means exclusively, in SMEs. This is a key activity to ensure the wider impact of HPC in this sector. It will include meaningful intellectual engagement between experts working in academia and users based in industry, with knowledge of HPC and an ability to facilitate access to the appropriate scale of resources required. Our dissemination channels and involvement in events (described in Sections 8 and 9) will also target industry stakeholders. The pharmaceutical industry is represented by our engagement with core partners Xxxxxx and Xxxxxxx, as well as our associate partners AstraZeneca, Institut Xxxxx and GSK. Also included in our consortium; Acellera, an R&D company that provides new technologies for the study of biophysical phenomena; and DNAnexus, a company that provides a global network for sharing and management of genomic data and tools to accelerate genomics. We will track work done by the ASME sub-committee V&V-40 on the verification and validation of modelling and simulation for the design and assessment of biomedical products, and the related USA Food and Drug Administration (FDA) Fast Track initiative, for the use of computer modelling and simulation results in regulatory processes. We will also monitor the work of the European Federation of Pharmaceutical Industries and Associations (EFPIA) with the European Medicine Agency (EMA) in relation to pharmaceutical products. We will seek to include representatives of these bodies in our activities. Through the involvement of our industry partners, we also expect to disseminate the importance of computer based, predictive, multiscale mechanistic modelling and how it can impact on drug design in an increasingly personalised environment, and to co-design industry- oriented added-value workflows that will contribute to the long-term sustainability of the XxX. The importance of serious compute capability is represented through our partnership with Atos. Despite the inexorable advances in medical science, the cost of discovery and bringing to market of new drugs is becoming prohibitive. The pharma R&D mo...
Industry. The party receiving any Confidential Information of the other party agrees to maintain the confidential status of such Confidential Information for a period of 2 years from the date of disclosure and not to use any such Confidential Information for any purpose other than the purposes for which it was originally disclosed to the receiving party, and not to disclose any of such Confidential Information to any third party. Upon expiration or termination of this Agreement, the receiving party shall return promptly to the other party or destroy, at that party's option, all tangible materials that disclose or embody Confidential Information.
